Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.

Boeddinghaus J, Bima P, Crisanti L, Keller DI, Slankamenac K, Christ M, Schuetz P, Wiencierz A, Strebel I, Reinhardt J, Vyshnevska I, Tsao TY, Ruggieri MP, Steuer S, Miró Ò, Harjola VP, Morello F, Nazerian P, Roth D, Zamorano JL, Gannon DE, Pott J, Bloom B, Zubaid R, Bicette R, Cuculici A, Bueno H, Sanchis J, Mahfoud F, Abubakr MOA, Yang HS, Mueller C, PRESC1SE-MI investigators

Open source

DOI
10.1016/s0140-6736(26)01654-5
Published
2026 Aug 29
Container
Lancet (London, England)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01654-5,
  title = {Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.},
  author = {Boeddinghaus J and Bima P and Crisanti L and Keller DI and Slankamenac K and Christ M and Schuetz P and Wiencierz A and Strebel I and Reinhardt J and Vyshnevska I and Tsao TY and Ruggieri MP and Steuer S and Miró Ò and Harjola VP and Morello F and Nazerian P and Roth D and Zamorano JL and Gannon DE and Pott J and Bloom B and Zubaid R and Bicette R and Cuculici A and Bueno H and Sanchis J and Mahfoud F and Abubakr MOA and Yang HS and Mueller C and PRESC1SE-MI investigators},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(26)01654-5},
  url = {https://doi.org/10.1016/s0140-6736(26)01654-5}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.
AU  - Boeddinghaus J
AU  - Bima P
AU  - Crisanti L
AU  - Keller DI
AU  - Slankamenac K
AU  - Christ M
AU  - Schuetz P
AU  - Wiencierz A
AU  - Strebel I
AU  - Reinhardt J
AU  - Vyshnevska I
AU  - Tsao TY
AU  - Ruggieri MP
AU  - Steuer S
AU  - Miró Ò
AU  - Harjola VP
AU  - Morello F
AU  - Nazerian P
AU  - Roth D
AU  - Zamorano JL
AU  - Gannon DE
AU  - Pott J
AU  - Bloom B
AU  - Zubaid R
AU  - Bicette R
AU  - Cuculici A
AU  - Bueno H
AU  - Sanchis J
AU  - Mahfoud F
AU  - Abubakr MOA
AU  - Yang HS
AU  - Mueller C
AU  - PRESC1SE-MI investigators
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01654-5
UR  - https://doi.org/10.1016/s0140-6736(26)01654-5
ER  - 

APA

J, B., P, B., L, C., DI, K., K, S., M, C., P, S., A, W., I, S., J, R., I, V., TY, T., MP, R., S, S., Ò, M., VP, H., F, M., P, N., D, R., JL, Z., DE, G., J, P., B, B., R, Z., R, B., A, C., H, B., J, S., F, M., MOA, A., HS, Y., C, M., & investigators, P. (2026). Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01654-5

Source records